Article info
PDFEBM analysis
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression
- Correspondence to Dr Michael P Hengartner, Department of Applied Psychology, Zurich University of Applied Sciences, 8400 Winterthur, Switzerland; michaelpascal.hengartner{at}zhaw.ch
Citation
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression
Publication history
- Accepted January 22, 2021
- First published February 16, 2021.
Online issue publication
March 23, 2022
Article Versions
- Previous version (23 March 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.